Published 4 hours ago • loading... • Updated 1 hour ago
Weight-Loss Drugs’ Hit to UK Grocery Spending Tops £1 Billion, Worldpanel Says
Worldpanel said 2.6 million households now use the drugs, with spending on alcohol and crisps down 15% and frozen ready meals up 30%.
On Thursday, researcher Worldpanel by Numerator reported that GLP-1 drugs have displaced more than £1 billion in British grocery spending, with user households spending £1 billion less than expected in the year after adoption.
The proportion of British households using GLP-1 drugs, including Eli Lilly's Mounjaro and Novo Nordisk's Wegovy, has risen from 6.3% in February to 8.5% in August, with men now representing 32% of users.
This displaced spending equates to £389 a year for each user household, while spending on alcohol and crisps among users has fallen 15% more than in non-user households.
Volume sales of frozen ready meals have risen 30% among users, reflecting a shift toward easy, portion-controlled options as purchasing habits change.
Worldpanel estimates suggest GLP-1 usage may surpass 10% of British households by 2027. "Despite regulatory approval only coming in June, pills, account for 11.2% of UK GLP-1 users.
For every British household with at least one member using GLP-1 drugs, the reduction is estimated at 389 pounds per year.
The post Along with weight, weight loss drugs also reduce food spending appeared first on in.gr.